15 doctors weighed in:
Is evista (raloxifene) as effective as tamoxifen in reducing breast cancer?
15 doctors weighed in

Dr. Barry Rosen
Surgery
13 doctors agree
In brief: Yes (and no)
The study of tamoxifen and Raloxifene (star) trial compared the effectiveness of these two drugs in the prevention of breast cancer and found them to be equally effective, with a 50% reduction in invasive breast cancer as compared to placebo.
However, only tamoxifen reduced the rate of carcinoma in situ (dcis, lcis).

In brief: Yes (and no)
The study of tamoxifen and Raloxifene (star) trial compared the effectiveness of these two drugs in the prevention of breast cancer and found them to be equally effective, with a 50% reduction in invasive breast cancer as compared to placebo.
However, only tamoxifen reduced the rate of carcinoma in situ (dcis, lcis).
Dr. Barry Rosen
Dr. Barry Rosen
Thank
Dr. Deanna Attai
Breast Surgery
1 doctor agrees
In brief: For invasive cancer
Evista (raloxifene) and tamoxifen were compared in the star trial.
The results showed that Evista (raloxifene) was just as effective as reducing the risk of invasive cancer as tamoxifen with fewer side effects. There was no difference in the risk of developing dcis, ore ductal carcinoma in-situ.

In brief: For invasive cancer
Evista (raloxifene) and tamoxifen were compared in the star trial.
The results showed that Evista (raloxifene) was just as effective as reducing the risk of invasive cancer as tamoxifen with fewer side effects. There was no difference in the risk of developing dcis, ore ductal carcinoma in-situ.
Dr. Deanna Attai
Dr. Deanna Attai
Thank
Get help from a real doctor now
Dr. Dennis Higginbotham
Board Certified, Obstetrics & Gynecology
26 years in practice
49M people helped
Continue
108,000 doctors available
Read more answers from doctors